The possibility that abnormal Apo composition may lead to the onset of MetS—including significant weight gain, hypertriglyceridemia, and hypercholesterolemia—cannot be excluded; therefore, systematic follow-up for this condition is necessary in this population. The gene discussed is AOPEP; the disease is metabolic syndrome.